Brief: Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
21/11/2023 13:02
Nov 21 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES FILES 510(K) SUBMISSION WITH U.S. FDA
FOR ITS
CELLFX NSPFA PERCUTANEOUS ELECTRODE
Source text for Eikon: ID:nBw1cJjhPa
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsBrief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants
Chairmen Total Approximately $13.3 Million
Pulse Biosciences records Q1 revenue, but loss widens on higher clinical investment
Brief: Pulse Biosciences Q1 Net Income USD -18.581 Million
Brief: Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System